Global burden of blindness and vision loss among children and adolescents: A systematic analysis for the global burden of disease study 2021
Asia-Pacific Journal of Ophthalmology · 2025
DOI: 10.1016/j.apjo.2025.100200 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asia-Pacific Journal of Ophthalmology, 2025. Verfasst von Yinwen Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Visual Sciences, the Chinese University of Hong Kong, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Blindness. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
AIM: This study investigates the global burden of vision impairment caused by refraction disorders, near vision loss, and other vision loss among children and adolescents from 1990 to 2021. The analysis is categorized globally by sex, age, and socio-demographic index (SDI), with a focus on predicting trends to 2035. METHODS: Data weas obtained from the Global Burden of Disease Study 2021. We reported the prevalence and disability-adjusted life-years (DALYs) of vision impairment due to refraction disorders, near vision loss, and other vision loss globally. Then, we described the prevalence and DALYs numbers and rates by sex, SDI and age. Next, we analyzed the relationship between rate and SDI. Finally, bayesian age-period-cohort (BAPC) analysis model was used to predict the trends from 2022 to 2035 globally by sex and age. RESULTS: The prevalence and DALYs rates for refraction disorders had a statistically significant trend of reduction in four age groups globally and were positively associated with SDI. The prevalence and DALYs rates for near vision loss were increasing in four age groups, and were negatively associated with SDI. The BAPC model indicates that the age-specific prevalence and DALYs rates of refraction disorders and other vision loss in both men and women will remain on a downward trend until 2035, while near vision loss continues to rise. CONCLUSIONS: The findings underscore that there are extensive variations based on the type of vision impairment, age group, sex and SDI. Policies should be tailored to specific types in order to effectively alleviate the burden.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology and Visual Sciences, the Chinese University of Hong Kong, Hong Kong SAR, China.
- Department of Ophthalmology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
- Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China.
- Department of Ophthalmology and Visual Sciences, the Chinese University of Hong Kong, Hong Kong SAR, China; Department of Ophthalmology and Visual Sciences, Prince of Wales Hospital, Hong Kong SAR, China; Hong Kong Hub…
- Department of Ophthalmology and Visual Sciences, the Chinese University of Hong Kong, Hong Kong SAR, China; Hong Kong Eye Hospital, Hong Kong SAR, China; Department of Ophthalmology and Visual Sciences, Prince of Wales…
Zitieren
APA
Li, Y., Shu, Y., Qian, T., Zhang, Y., Chen, L., & Yam, J. C. (2025). Global burden of blindness and vision loss among children and adolescents: A systematic analysis for the global burden of disease study 2021. Asia-Pacific Journal of Ophthalmology. https://doi.org/10.1016/j.apjo.2025.100200
Vancouver
Li Y, Shu Y, Qian T, Zhang Y, Chen L, Yam JC. Global burden of blindness and vision loss among children and adolescents: A systematic analysis for the global burden of disease study 2021. Asia-Pacific Journal of Ophthalmology. 2025. doi:10.1016/j.apjo.2025.100200
BibTeX
@article{Li2025,
author = {Li, Yinwen and Shu, Yiyang and Qian, Tianwei and Zhang, Yuzhou and Chen, Lijia and Yam, Jason C},
title = {Global burden of blindness and vision loss among children and adolescents: A systematic analysis for the global burden of disease study 2021},
journal = {Asia-Pacific Journal of Ophthalmology},
year = {2025},
doi = {10.1016/j.apjo.2025.100200}
}
EUVIMED